1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Osteogenesis Imperfecta Global Clinical Trials Review, H2, 2015

Osteogenesis Imperfecta Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Osteogenesis Imperfecta Global Clinical Trials Review, H2, 2015" provides an overview of Osteogenesis Imperfecta clinical trials scenario. This report provides top line data relating to the clinical trials on Osteogenesis Imperfecta. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Osteogenesis Imperfecta Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Osteogenesis Imperfecta 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Osteogenesis Imperfecta Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Novartis AG 29
Clinical Trial Overview of Novartis AG 29
Eli Lilly and Company 30
Clinical Trial Overview of Eli Lilly and Company 30
Axellus A/S 31
Clinical Trial Overview of Axellus A/S 31
Arthritis Research UK 32
Clinical Trial Overview of Arthritis Research UK 32
Amgen Inc. 33
Clinical Trial Overview of Amgen Inc. 33
Allergan Plc 34
Clinical Trial Overview of Allergan Plc 34
Clinical Trial Overview of Top Institutes / Government 35
Hospital de Cruces 35
Clinical Trial Overview of Hospital de Cruces 35
Indiana University School of Medicine 36
Clinical Trial Overview of Indiana University School of Medicine 36
Oregon Health and Science University 37
Clinical Trial Overview of Oregon Health and Science University 37
Peking Union Medical College Hospital 38
Clinical Trial Overview of Peking Union Medical College Hospital 38
Shriners Hospitals for Children 39
Clinical Trial Overview of Shriners Hospitals for Children 39
St. Jude Children's Research Hospital, Inc. 40
Clinical Trial Overview of St. Jude Children's Research Hospital, Inc. 40
Tohoku University School of Medicine 41
Clinical Trial Overview of Tohoku University School of Medicine 41
University of Cologne 42
Clinical Trial Overview of University of Cologne 42
Five Key Clinical Profiles 43
Appendix 84
Abbreviations 84
Definitions 84
Research Methodology 85
Secondary Research 85
About GlobalData 86
Contact Us 86
Disclaimer 86
Source 87

List of Tables
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Region, 2015* 7
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Osteogenesis Imperfecta Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Osteogenesis Imperfecta Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Osteogenesis Imperfecta Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Osteogenesis Imperfecta Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Osteogenesis Imperfecta Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Osteogenesis Imperfecta Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Phase, 2015* 20
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 21
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Osteogenesis Imperfecta Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 25
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 29
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2015* 30
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Axellus A/S, 2015* 31
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Arthritis Research UK, 2015* 32
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2015* 33
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015* 34
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital de Cruces, 2015* 35
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2015* 36
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Oregon Health and Science University, 2015* 37
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Peking Union Medical College Hospital, 2015* 38
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2015* 39
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2015* 40
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University School of Medicine, 2015* 41
Osteogenesis Imperfecta Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cologne, 2015* 42

List of Figures
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Osteogenesis Imperfecta Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Osteogenesis Imperfecta Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Osteogenesis Imperfecta Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Osteogenesis Imperfecta Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, G7 Countries (%), 2015* 15
Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Osteogenesis Imperfecta Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Osteogenesis Imperfecta to Genetic Disorders Clinical Trials, E7 Countries (%), 2015* 18
Osteogenesis Imperfecta Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Phase (%), 2015* 20
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 21
Osteogenesis Imperfecta Therapeutics, Global, Clinical Trials by Trial Status, 2015* 22
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, by End Point Status, 2015* 23
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 24
Osteogenesis Imperfecta Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 25
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 26
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 27
Osteogenesis Imperfecta Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 28
GlobalData Methodology 85

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.